ID PPAF_PHAVU Reviewed; 459 AA. AC P80366; O24319; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 26-NOV-2014, sequence version 3. DT 24-JAN-2024, entry version 134. DE RecName: Full=Fe(3+)-Zn(2+) purple acid phosphatase {ECO:0000303|PubMed:8001554}; DE Short=PAP {ECO:0000303|PubMed:8001554}; DE EC=3.1.3.2 {ECO:0000269|PubMed:12054466, ECO:0000269|PubMed:22943065}; DE AltName: Full=Iron(III)-zinc(II) purple acid phosphatase {ECO:0000305|PubMed:8001554}; DE Flags: Precursor; OS Phaseolus vulgaris (Kidney bean) (French bean). OC Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta; OC Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae; OC rosids; fabids; Fabales; Fabaceae; Papilionoideae; 50 kb inversion clade; OC NPAAA clade; indigoferoid/millettioid clade; Phaseoleae; Phaseolus. OX NCBI_TaxID=3885; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, ACTIVITY REGULATION, RP BIOPHYSICOCHEMICAL PROPERTIES, AND BLOCKAGE OF N-TERMINUS. RC TISSUE=Seed {ECO:0000312|EMBL:CAA04644.1}; RX PubMed=12054466; DOI=10.1016/s0003-9861(02)00046-2; RA Vogel A., Borchers T., Marcus K., Meyer H.E., Krebs B., Spener F.; RT "Heterologous expression and characterization of recombinant purple acid RT phosphatase from red kidney bean."; RL Arch. Biochem. Biophys. 401:164-172(2002). RN [2] RP PROTEIN SEQUENCE OF 28-459. RC TISSUE=Seed {ECO:0000303|PubMed:8001554}; RX PubMed=8001554; DOI=10.1111/j.1432-1033.1994.tb20061.x; RA Klabunde T., Stahl B., Suerbaum H., Hahner S., Karas M., Hillenkamp F., RA Krebs B., Witzel H.; RT "The amino acid sequence of the red kidney bean Fe(III)-Zn(II) purple acid RT phosphatase. Determination of the amino acid sequence by a combination of RT matrix-assisted laser desorption/ionization mass spectrometry and automated RT Edman sequencing."; RL Eur. J. Biochem. 226:369-375(1994). RN [3] RP PARTIAL PROTEIN SEQUENCE, AND GLYCOSYLATION AT ASN-108; ASN-136; ASN-170; RP ASN-238 AND ASN-423. RC TISSUE=Seed; RX PubMed=8125089; DOI=10.1111/j.1432-1033.1994.tb18628.x; RA Stahl B., Klabunde T., Witzel H., Krebs B., Steup M., Karas M., RA Hillenkamp F.; RT "The oligosaccharides of the Fe(III)-Zn(II) purple acid phosphatase of the RT red kidney bean. Determination of the structure by a combination of matrix- RT assisted laser desorption/ionization mass spectrometry and selective RT enzymic degradation."; RL Eur. J. Biochem. 220:321-330(1994). RN [4] RP X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS), COFACTOR, SUBUNIT, AND ACTIVE SITE. RX PubMed=7770774; DOI=10.1126/science.7770774; RA Straeter N., Klabunde T., Tucker P., Witzel H., Krebs B.; RT "Crystal structure of a purple acid phosphatase containing a dinuclear RT Fe(III)-Zn(II) active site."; RL Science 268:1489-1492(1995). RN [5] RP X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS), COFACTOR, SUBUNIT, GLYCOSYLATION AT RP ASN-108; ASN-136; ASN-170; ASN-238 AND ASN-423, DISULFIDE BOND, AND ACTIVE RP SITE. RX PubMed=8683579; DOI=10.1006/jmbi.1996.0354; RA Klabunde T., Straeter N., Froehlich R., Witzel H., Krebs B.; RT "Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal RT structures."; RL J. Mol. Biol. 259:737-748(1996). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 34-459 IN COMPLEX WITH INHIBITOR, RP CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION, SUBUNIT, DISULFIDE BOND, RP AND GLYCOSYLATION AT ASN-108; ASN-136; ASN-170 AND ASN-423. RX PubMed=22943065; DOI=10.1111/cbdd.12001; RA Feder D., Hussein W.M., Clayton D.J., Kan M.W., Schenk G., McGeary R.P., RA Guddat L.W.; RT "Identification of purple acid phosphatase inhibitors by fragment-based RT screening: promising new leads for osteoporosis therapeutics."; RL Chem. Biol. Drug Des. 80:665-674(2012). CC -!- CATALYTIC ACTIVITY: CC Reaction=a phosphate monoester + H2O = an alcohol + phosphate; CC Xref=Rhea:RHEA:15017, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:67140; EC=3.1.3.2; CC Evidence={ECO:0000269|PubMed:12054466, ECO:0000269|PubMed:22943065}; CC -!- COFACTOR: CC Name=Fe cation; Xref=ChEBI:CHEBI:24875; CC Note=Binds 1 Fe cation per subunit. {ECO:0000269|PubMed:22943065, CC ECO:0000269|PubMed:7770774, ECO:0000269|PubMed:8683579}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:22943065, CC ECO:0000269|PubMed:7770774, ECO:0000269|PubMed:8683579}; CC -!- ACTIVITY REGULATION: Inhibited by compounds CC24201, CC27209, and CC MO07123 (PubMed:22943065). Inhibited by the tetraoxoanions molybdate CC and phosphate (PubMed:12054466). Not inhibited by EDTA or tartrate CC (PubMed:12054466). {ECO:0000269|PubMed:12054466, CC ECO:0000269|PubMed:22943065}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC pH dependence: CC Optimum pH is 6.1. {ECO:0000269|PubMed:12054466}; CC -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000269|PubMed:22943065, CC ECO:0000269|PubMed:7770774, ECO:0000269|PubMed:8683579}. CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000303|PubMed:12054466}. CC -!- SIMILARITY: Belongs to the metallophosphoesterase superfamily. Purple CC acid phosphatase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ001270; CAA04644.1; -; mRNA. DR PDB; 1KBP; X-ray; 2.65 A; A/B/C/D=28-459. DR PDB; 2QFP; X-ray; 2.20 A; A/B/C/D=36-459. DR PDB; 2QFR; X-ray; 2.40 A; A/B=36-459. DR PDB; 3KBP; X-ray; 3.00 A; A/B/C/D=28-459. DR PDB; 4DHL; X-ray; 2.30 A; A/B/C/D=34-459. DR PDB; 4DSY; X-ray; 2.30 A; A/B/C/D=34-459. DR PDB; 4DT2; X-ray; 2.70 A; A/B/C/D=34-459. DR PDB; 4KBP; X-ray; 2.70 A; A/B/C/D=28-459. DR PDB; 6G46; X-ray; 2.40 A; A/B/C/D=34-459. DR PDB; 6HWR; X-ray; 1.95 A; A/B/C/D=34-459. DR PDB; 6OF5; X-ray; 2.30 A; A/B/C/D=34-459. DR PDB; 6OFD; X-ray; 2.20 A; A/B/C/D=1-459. DR PDB; 6PY9; X-ray; 2.20 A; A/B/C/D=1-459. DR PDB; 6VJ7; X-ray; 2.60 A; A/B/C/D=34-459. DR PDB; 8BRN; X-ray; 2.00 A; A/B/C/D=32-459. DR PDBsum; 1KBP; -. DR PDBsum; 2QFP; -. DR PDBsum; 2QFR; -. DR PDBsum; 3KBP; -. DR PDBsum; 4DHL; -. DR PDBsum; 4DSY; -. DR PDBsum; 4DT2; -. DR PDBsum; 4KBP; -. DR PDBsum; 6G46; -. DR PDBsum; 6HWR; -. DR PDBsum; 6OF5; -. DR PDBsum; 6OFD; -. DR PDBsum; 6PY9; -. DR PDBsum; 6VJ7; -. DR PDBsum; 8BRN; -. DR AlphaFoldDB; P80366; -. DR SMR; P80366; -. DR BindingDB; P80366; -. DR ChEMBL; CHEMBL5670; -. DR GlyConnect; 306; 12 N-Linked glycans. DR iPTMnet; P80366; -. DR eggNOG; KOG1378; Eukaryota. DR BRENDA; 3.1.3.2; 4746. DR SABIO-RK; P80366; -. DR EvolutionaryTrace; P80366; -. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0003993; F:acid phosphatase activity; IDA:UniProtKB. DR GO; GO:0008199; F:ferric iron binding; IDA:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB. DR CDD; cd00839; MPP_PAPs; 1. DR Gene3D; 3.60.21.10; -; 1. DR Gene3D; 2.60.40.380; Purple acid phosphatase-like, N-terminal; 1. DR InterPro; IPR004843; Calcineurin-like_PHP_ApaH. DR InterPro; IPR029052; Metallo-depent_PP-like. DR InterPro; IPR041792; MPP_PAP. DR InterPro; IPR039331; PPA-like. DR InterPro; IPR008963; Purple_acid_Pase-like_N. DR InterPro; IPR015914; Purple_acid_Pase_N. DR InterPro; IPR025733; Purple_acid_PPase_C_dom. DR PANTHER; PTHR22953; ACID PHOSPHATASE RELATED; 1. DR PANTHER; PTHR22953:SF86; PURPLE ACID PHOSPHATASE 10; 1. DR Pfam; PF00149; Metallophos; 1. DR Pfam; PF14008; Metallophos_C; 1. DR Pfam; PF16656; Pur_ac_phosph_N; 1. DR SUPFAM; SSF56300; Metallo-dependent phosphatases; 1. DR SUPFAM; SSF49363; Purple acid phosphatase, N-terminal domain; 1. PE 1: Evidence at protein level; KW 3D-structure; Direct protein sequencing; Disulfide bond; Glycoprotein; KW Hydrolase; Iron; Metal-binding; Secreted; Signal; Zinc. FT SIGNAL 1..22 FT /evidence="ECO:0000255, ECO:0000303|PubMed:12054466" FT CHAIN 23..459 FT /note="Fe(3+)-Zn(2+) purple acid phosphatase" FT /evidence="ECO:0000255, ECO:0000303|PubMed:12054466" FT /id="PRO_0000114474" FT ACT_SITE 323 FT /note="Proton donor" FT /evidence="ECO:0000303|PubMed:7770774, FT ECO:0000303|PubMed:8683579" FT BINDING 162 FT /ligand="Fe cation" FT /ligand_id="ChEBI:CHEBI:24875" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 191 FT /ligand="Fe cation" FT /ligand_id="ChEBI:CHEBI:24875" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 191 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 194 FT /ligand="Fe cation" FT /ligand_id="ChEBI:CHEBI:24875" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 228 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 313 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 350 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT BINDING 352 FT /ligand="Fe cation" FT /ligand_id="ChEBI:CHEBI:24875" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT MOD_RES 23 FT /note="Blocked amino end (Gly)" FT /evidence="ECO:0000269|PubMed:12054466" FT CARBOHYD 108 FT /note="N-linked (GlcNAc...) asparagine; partial" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8125089, ECO:0000269|PubMed:8683579" FT CARBOHYD 136 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8125089, ECO:0000269|PubMed:8683579" FT CARBOHYD 170 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8125089, ECO:0000269|PubMed:8683579" FT CARBOHYD 238 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:8125089, FT ECO:0000269|PubMed:8683579" FT CARBOHYD 423 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8125089, ECO:0000269|PubMed:8683579" FT DISULFID 372 FT /note="Interchain" FT /evidence="ECO:0000269|PubMed:22943065, FT ECO:0000269|PubMed:8683579" FT CONFLICT 280..281 FT /note="YS -> HI (in Ref. 2; AA sequence)" FT CONFLICT 369 FT /note="N -> D (in Ref. 2; AA sequence)" FT HELIX 43..45 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 55..61 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 63..67 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 69..78 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 84..88 FT /evidence="ECO:0007829|PDB:6HWR" FT TURN 89..91 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 95..97 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 100..102 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 113..119 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 127..132 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 135..137 FT /evidence="ECO:0007829|PDB:2QFP" FT STRAND 139..144 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 155..160 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 164..166 FT /evidence="ECO:0007829|PDB:6VJ7" FT HELIX 167..177 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 184..188 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 195..197 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 199..201 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 204..217 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 222..224 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 228..231 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 235..237 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 244..249 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 254..257 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 264..269 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 272..276 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 288..299 FT /evidence="ECO:0007829|PDB:6HWR" FT TURN 302..304 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 307..311 FT /evidence="ECO:0007829|PDB:6HWR" FT TURN 322..327 FT /evidence="ECO:0007829|PDB:6HWR" FT HELIX 328..340 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 345..348 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 350..357 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 359..361 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 367..369 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 382..386 FT /evidence="ECO:0007829|PDB:6HWR" FT TURN 391..393 FT /evidence="ECO:0007829|PDB:1KBP" FT STRAND 407..411 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 415..421 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 423..433 FT /evidence="ECO:0007829|PDB:6HWR" FT STRAND 442..448 FT /evidence="ECO:0007829|PDB:6HWR" FT TURN 450..452 FT /evidence="ECO:0007829|PDB:6HWR" SQ SEQUENCE 459 AA; 52857 MW; CC379B7C1AE4D21A CRC64; MGVVKGLLAL ALVLNVVVVS NGGKSSNFVR KTNKNRDMPL DSDVFRVPPG YNAPQQVHIT QGDLVGRAMI ISWVTMDEPG SSAVRYWSEK NGRKRIAKGK MSTYRFFNYS SGFIHHTTIR KLKYNTKYYY EVGLRNTTRR FSFITPPQTG LDVPYTFGLI GDLGQSFDSN TTLSHYELSP KKGQTVLFVG DLSYADRYPN HDNVRWDTWG RFTERSVAYQ PWIWTAGNHE IEFAPEINET EPFKPFSYRY HVPYEASQST SPFWYSIKRA SAHIIVLSSY SAYGRGTPQY TWLKKELRKV KRSETPWLIV LMHSPLYNSY NHHFMEGEAM RTKFEAWFVK YKVDVVFAGH VHAYERSERV SNIAYKITNG LCTPVKDQSA PVYITIGDAG NYGVIDSNMI QPQPEYSAFR EASFGHGMFD IKNRTHAHFS WNRNQDGVAV EADSVWFFNR HWYPVDDST //